This CTD dossier owner and manufacturer is a pharmaceutical manufacturer with a focus on producing a wide range of healthcare products. They specialize in musculoskeletal medications for conditions like osteoarthritis, gout, and pain relief. Their portfolio also includes antipyretics, anti-inflammatories, allergy treatments, antiviral drugs, and digestive health remedies. They offer various dosage forms including tablets, capsules, and liquids. The company emphasizes quality control with GMP certifications and holds patents on several of their products. They primarily serve markets in the EU and North America. Their product line extends beyond pharmaceuticals to include bird's nest supplements and other health-focused items.

Established in 1975, this Manufacturer is a prominent CTD dossier owner and manufacturer based in Ho Chi Minh City, Vietnam. As a GMP manufacturer, it operates a state-of-the-art facility in Tan Tao Industrial Park, adhering to GMP-WHO standards. The Manufacturer's diverse product portfolio includes tablets, film-coated tablets, sugar-coated tablets, soft capsules, granules, and powders, catering to therapeutic areas such as respiratory, cardiovascular, and digestive health. With a commitment to quality and innovation, this CTD dossier owner and manufacturer continues to expand its presence in both domestic and international markets.

Established in 1977, this Manufacturer is a leading CTD dossier owner and manufacturer in Vietnam, employing approximately 1,400 professionals. As a GMP manufacturer, it operates four factory clusters across Dong Thap, Ho Chi Minh City, and Binh Duong, with three clusters meeting EU-GMP standards and housing 11 production lines. The Manufacturer's diverse product portfolio includes antibiotics, cardiovascular treatments, and vitamins, distributed both domestically and internationally. As a CTD dossier owner and manufacturer, it ensures compliance with stringent regulatory requirements. Committed to excellence, this GMP manufacturer continues to expand its presence in regulated markets